Artwork

Content provided by Anesthesiology News, James Prudden, and Paul Bufano. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Anesthesiology News, James Prudden, and Paul Bufano or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Ep 3: Government in Action or Inaction (The Etherist, Season 1)

30:57
 
Share
 

Manage episode 246330196 series 2571362
Content provided by Anesthesiology News, James Prudden, and Paul Bufano. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Anesthesiology News, James Prudden, and Paul Bufano or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
From the shortages of quinine during the U.S. Civil War to the sudden lack of saline bags in the wake of Hurricane Maria, the pharmaceutical manufacturing industry has continued to struggle with health care demands. Those resulting shortages have led to unique and complicated situations across the country throughout modern medical history. But one organization has always had the power to create meaningful change in that overburdened industry: the federal government. Using regulatory agencies and legislative efforts, people within government could use that power to force shifts in manufacturing practices to improve outcomes and eliminate disruptions in the drug supply chain. And after all this time the question still remains: Where should they start? How can the very same regulators and legislators who watched these problems arise make the necessary changes to reverse the course in this drug shortage crisis? Join us as we explore the possibilities of government action to fix the drug manufacturing system.
  continue reading

53 episodes

Artwork
iconShare
 
Manage episode 246330196 series 2571362
Content provided by Anesthesiology News, James Prudden, and Paul Bufano. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Anesthesiology News, James Prudden, and Paul Bufano or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
From the shortages of quinine during the U.S. Civil War to the sudden lack of saline bags in the wake of Hurricane Maria, the pharmaceutical manufacturing industry has continued to struggle with health care demands. Those resulting shortages have led to unique and complicated situations across the country throughout modern medical history. But one organization has always had the power to create meaningful change in that overburdened industry: the federal government. Using regulatory agencies and legislative efforts, people within government could use that power to force shifts in manufacturing practices to improve outcomes and eliminate disruptions in the drug supply chain. And after all this time the question still remains: Where should they start? How can the very same regulators and legislators who watched these problems arise make the necessary changes to reverse the course in this drug shortage crisis? Join us as we explore the possibilities of government action to fix the drug manufacturing system.
  continue reading

53 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide